These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9588246)

  • 21. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 23. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of NSAID-induced ulcer disease.
    Clearfield HR
    Am Fam Physician; 1992 Jan; 45(1):255-8. PubMed ID: 1728095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal anti-inflammatory drug use in dentistry: gastrointestinal implications.
    Nguyen AM; Graham DY; Gage T; Griffiths GR
    Gen Dent; 1999; 47(6):590-6; quiz 597-8. PubMed ID: 10687453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE; Murav'ev IuV; Radenska-Lopovok SG; Nasonova VA
    Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to Ray and colleagues: the called-for large clinical trial is already ongoing.
    Peura D; Chan FK; Wilcox CM; Niculescu L; Berger M
    Gastroenterology; 2008 Jan; 134(1):370-1; author reply 371. PubMed ID: 18166374
    [No Abstract]   [Full Text] [Related]  

  • 30. [NSAID-induced ulcer and its complications].
    Aly A
    Nord Med; 1997 Jun; 112(6):195-7. PubMed ID: 9273513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
    Yeomans ND; Svedberg LE; Naesdal J
    Int J Clin Pract; 2006 Nov; 60(11):1401-7. PubMed ID: 17073837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
    Hawkey CJ
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265
    [No Abstract]   [Full Text] [Related]  

  • 33. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM
    J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lansoprazole: an analysis of the clinical trials in the 3 years of 1997-1999].
    Dobrilla G; Capurso L
    Recenti Prog Med; 2000 Apr; 91(4):191-210. PubMed ID: 10804753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing NSAID-induced ulcers: the use of misoprostol.
    Lynn MM; Holdcroft C
    Nurse Pract; 1990 Oct; 15(10):38-9, 42. PubMed ID: 2122334
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
    Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB
    Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NSAID ulcer (H. pylori, treatment, prevention)].
    Ohta S; Arai S; Imai Y; Banba H
    Nihon Rinsho; 2004 Mar; 62(3):505-11. PubMed ID: 15038095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].
    Lesur G
    Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.